Curcumin augments cytostatic and anti-invasive effects of mitoxantrone on carcinosar-coma cells in vitro
Abstract
Numerous adverse effects limit the applicability of mitoxantrone for the treatment of drug-resistant tumors, including carcinosarcoma. Here, we estimated the additive effects of mitoxantrone and curcumin, a plant-derived biomolecule isolated from Curcuma longa, on the neoplastic and invasive potential of carcinosarcoma cells in vitro. Curcumin augmented cytostatic, cytotoxic and anti-invasive effects of mitoxantrone on Walker-256 cells. It also strengthened inhibitory effects of mitoxantrone on the motility of drug-resistant Walker-256 cells that had retained the viability after long-term mitoxantrone/curcumin treatment. Thus, curcumin reduces the effective doses of mitoxantrone and augments its interference with the invasive potential of drug-resistant carcinosarcoma cells.
References
Alem HB, AlNoury MK (2014) Management of Spindle Cell Carcinoma of the Maxillary Sinus: A Case Report and Literature Review. Am J Case Rep 15: 454–458. http://doi.org/10.12659/AJCR.891007
Bidaud-Meynard A, Arma D, Taouji S, Laguerre M, Dessolin J, Rosenbaum J, Chevet E, Moreau V (2013) A novel small-molecule screening strategy identifies mitoxantrone as a RhoGTPase inhibitor, Biochem J 62: 55–62. http://doi.org/10.1042/BJ20120572
Bigby SM, Charlton A, Miller MV, Zwi LJ, Oliver GF (2005) Biphasic sarcomatoid basal cell carcinoma (carcinosarcoma): four cases with immunohistochemistry and review of the literature. J Cutan Pathol 32(2): 141–147. http://doi: 10.1111/j.0303-6987.2005.00276.x
Carcano C, Savage E, Diacovo MJ, Kirsch J (2012) Bronchial carcinosarcoma, J Radiol Case Rep 6(10): 26–31. http://doi.org/10.3941/jrcr.v6i10.1049
Chen B, Zhang Y, Wang Y, Rao J, Jiang X, Xu Z (2014) Curcumin inhibits proliferation of breast cancer cells through Nrf2-mediated down-regulation of Fen1 expression. Journal of Steroid Biochemistry and Molecular Biology 143: 11–18. http://doi.org/10.1016/j.jsbmb.2014.01.009
Chen QY, Zheng Y, Jiao DM, Chen FY, Hu HZ, Wu YQ, Song J, Yan J, Wu LJ, Lv GY (2014) ScienceDirect Curcumin inhibits lung cancer cell migration and invasion through Rac1-dependent signaling pathway. The Journal of Nutritional Biochemistry 25(2): 177–185. http://doi.org/10.1016/j.jnutbio.2013.10.004
Daniel-Wójcik A, Misztal K, Bechyne I, Sroka J, Miekus K, Madeja Z, Czyz J (2008) Cell motility affects the intensity of gap junctional coupling in prostate carcinoma and melanoma cell populations. Int J Oncol 33(2): 309–315. http://doi.org/10.3892/ijo
El-Bahr SM (2014) Effect of Curcumin on Hepatic Antioxidant Enzymes Activities and Gene Expressions in Rats Intoxicated with Aflatoxin B1. Phytother Res 29(1). http://doi: 10.1002/ptr.5239. Epub 2014 Oct 8.
Furlan SR, Kang DJ, Armas A (2013) Prostatic carcinosarcoma with Lung Metastases.Case Rep Oncol Med 1–3. http://doi: 10.1155/2013/790790
Gong C, Deng S, Wu Q, Xiang M, Wei X, Li L, Gao X, Wang B, Sun L, Chen Y, Li Y, Liu L, Qian Z, Wei Y (2013). Biomaterials Improving antiangiogenesis and anti-tumor activity of curcumin by biodegradable polymeric micelles. Biomaterials 34(4): 1413–1432. http://doi.org/10.1016/j.biomaterials.2012.10.068
Ide H, Yu J, Lu Y, China T, Kumamoto T, Koseki T, Muto S, Horie S (2010) Testosterone augments polyphenol-induced DNA damage response in prostate cancer cell line. LNCaP. Cancer Sci 102(2): 468-471 http://doi.org/10.1111/j.1349-7006.2010.01791.x
Kamm CP, Uitdehaag BM, Polman CH. C. H. (2014) Multiple sclerosis: current knowledge and future outlook. Eur Neurol 72: 132–141. http://doi.org/10.1159/000360528
Kanthan R, Senger JL (2011) Uterine carcinosarcomas (malignant mixed müllerian tumours): a review with special emphasis on the controversies in management. Obstet Gynecol Int
:470795. http://doi.org/10.1155/2011/470795
Karp JE, Garrett-Mayer E, Estey EH, Rudek MA, Smith BD, Greer JM, Drye DM, Mackey K, Dorcy KS, Gore SD, Levis MJ, McDevitt MA, Carraway HE, Pratz KW,Gladstone DE, Showel MM, Othus M, Doyle LA, Wright JJ, Pagel JM. (2012) Randomized phase II study of two schedules of flavopiridol given as timed sequential therapy with cytosine arabinoside and mitoxantrone for adults with newly diagnosed , poor-risk acute myelogenous leukemia. Haematologica 97(11): 1736–1742. http://doi.org/10.3324/haematol.2012.062539
Koczurkiewicz P, Podolak I, Wójcik KA, Galanty A, Madeja Z, Michalik M, Czyż J (2013) Lclet 4 enhances pro-apoptotic and anti-invasive effects of mitoxantrone on human prostate cancer cells — in vitro study. Acta Biochim Pol 60(3): 331–338.
Li L, Braiteh FS, Kurzrock R (2005) Liposome-Encapsulated Curcumin In Vitro and In Vivo Effects on Proliferation, Apoptosis, Signaling, and Angiogenesis. Cancer 104(6):1322-31. http://doi.org/10.1002/cncr.21300
Limtrakul P, Chearwae W, Shukla S, Phisalphong C, Ambudkar SV (2007) Modulation of function of three ABC drug mitoxantrone resistance protein ( ABCG2 ) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin , a major metabolite of curcumin. Mol Cell Biochem 296: 85–95. http://doi.org/10.1007/s11010-006-9302-8
Lin HJ, Su CC, Lu HF, Yang JS, Hsu SC, Ip SW, Wu JJ, Li YC, Ho CC, Wu CC, Chung JG (2010) Curcumin blocks migration and invasion of mouse-rat hybrid retina ganglion cells (N18) through the inhibition of MMP-2 , -9 ,FAK, Rho A and Rock-1 gene expression. Oncol Rep 23(3): 665–670. http://doi.org/10.3892/or
Liu CH, Huang HY (2012) Antimicrobial Activity of Curcumin-Loaded Myristic Acid Microemulsions against Staphylococcus epidermidis. Chem Pharm Bull (Tokyo) 60(9): 1118–1124.
Mapoung S, Pitchakarn P, Yodkeeree S, Ovatlarnporn C, Sakorn N, Limtrakul P (2016) Chemosensitizing effects of synthetic curcumin analogs on human multi-drug resistance leukemic cells. Chemico-Biological Interactions 244: 140–148. http://doi.org/10.1016/j.cbi.2015.12.001
Mehrabani D, Farjam M, Geramizadeh B, Tanideh N, Amini M, Panjehshahin MR. (2015) The Healing Effect of Curcumin on Burn Wounds in Rat. World J Plast Surg 4(1): 29-35
Muss HB, Bundy BN, Homesley HD, Wilbanks G (1987). Mitoxantrone in the treatment of advanced non-squamous carcinoma of the cervix ( A phase II trial of the gyneVol-ogic oncology group ). Invest New Drugs 5(2):199-202.
Negi N, Prakash P, Gupta ML, Mohapatra TM (2014) Possible Role of Curcumin as an Efflux Pump Inhibitor in Multi Drug Resistant Clinical Isolates of Pseudomonas aeruginosa. J Clin Diagn Res 8(10): 8–11. http://doi.org/10.7860/JCDR/2014/8329.4965
Prasad S, Tyagi AK, Aggarwal BB (2014) Recent Developments in Delivery , Bioavailability, Absorption and Metabolism of Curcumin: the Golden Pigment from Golden Spice. Can-cer Res Treat 46(1): 2–18. http://doi: 10.4143/crt.2014.46.1.2.
Qian Y, Ma J, Guo X, Sun J, Yu Y, Cao B, Zhang L, Ding X, Huang J, Shao JF (2015) Curcumin Enhances the Radiosensitivity of U87 Cells by Inducing DUSP-2 Up- Regulation. Cell Physiol Biochem 35(4): 1381–1393. http://doi.org/10.1159/000373959
Rivera VM, Jeffery DR, Weinstock-Guttman B, Bock D, Dangond F (2013) Results from the 5-year, phase IV RENEW (Registry to Evaluate Novantrone Effects in Worsening Multiple Sclerosis) study. BMC Neurology 13: 80 http://doi.org/10.1186/1471-2377-13-80
Santos AM, Lopes T, Oleastro M, Gato IV, Floch P, Benejat L, Chaves P, Pereira T, Seixas E, Machado J, Guerreiro AS (2015) Curcumin Inhibits Gastric Inflammation Induced by Helicobacter Pylori Infection in a Mouse Model. Nutrients 7(1): 306–320. http://doi.org/10.3390/nu7010306
Sarkar FH, Li Y (2006) Using Chemopreventive Agents to Enhance the Efficacy of Cancer Therapy. Cancer Res 66(7): 3347–3351. http://doi.org/10.1158/0008-5472.CAN-05-4526
Seo BR, Min KJ, Cho IJ, Kim SC, Kwon TK (2014) Curcumin Significantly Enhances Dual PI3K / Akt and mTOR Inhibitor NVP-BEZ235-Induced Apoptosis in Human Renal Carcinoma Caki Cells through Down- Regulation of p53-Dependent Bcl-2 Expression and Inhibition of Mcl-1 Protein Stability. PLoS One 9(4) http://doi.org/10.1371/journal.pone.0095588
Shariftabrizi A, Pellicciotta I, Abdullah A, Venditti CA, Samuelson R, Shahabi S (2015) Presence of both Mesenchymal and Carcinomatous Features in an In-vitro Model of Ovarian Carcinosarcoma Derived from Patients’ Ascitic Fluid. Int J Hematol Oncol Stem Cell Res 9(1): 3–6.
Sharma RA, Euden SA, Platton SL, Cooke DN, Shafayat A, Hewitt HR, Marczylo TH, Morgan B, Hemingway D, Plummer SM, Pirmohamed M, Gescher AJ,Steward WP (2004) Phase I Clinical Trial of Oral Curcumin: Biomarkers of Systemic Activity and Compliance. Clin Cancer Res 10: 6847–6854. http:// doi: 10.1158/1078-0432.CCR-04-0744
Shehzad A, Park JW, Lee J, Lee YS (2013) Curcumin induces radiosensitivity of in vitro and in vivo cancer models by modulating pre-mRNA processing factor 4 (Prp4). Chemico-biological interactions 206(2), 394–402. http://doi.org/10.1016/j.cbi.2013.10.007
Sroka J, von Gunten M, Dunn GA, Keller HU (2002) Phenotype modulation in non-adherent and adherent sublines of Walker carcinosarcoma cells: the role of cell-substratum contacts and microtubules in controlling cell shape, locomotion and cytoskeletal structure. Int J Biochem Cell Biol 34, 882–899.
Szwed, M (2014) Mitoxantrone – an anthraquinone antibiotic with antitumor activity applied for the treatment of multiple sclerosis. Postepy Hig Med Dosw (Online) 68: 198–208.
Wang BL, Shen YM, Zhang QW, Li YL, Luo M, Liu Z, Li Y, Qian ZY, Gao X, Shi HS (2013) Codelivery of curcumin and doxorubicin by MPEG-PCL results in improved efficacy of systemically administered chemotherapy in mice with lung cancer. Int J Nanomedicine 8: 3521–3531.
Zhao X, Chen Q, Liu W, Li Y, Tang H, Liu X, Yang X (2015) Codelivery of doxorubicin and curcumin with lipid nanoparticles results in improved efficacy of chemotherapy in liver cancer. Int J Nanomedicine 10: 257–270. http:// doi: 10.2147/IJN.S73322.
Acta Biochimica Polonica is an OpenAccess quarterly and publishes four issues a year. All contents are distributed under the Creative Commons Attribution-ShareAlike 4.0 International (CC BY 4.0) license. Everybody may use the content following terms: Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
Copyright for all published papers © stays with the authors.
Copyright for the journal: © Polish Biochemical Society.
